BRAIN Biotech AG

XTRA:BNN Stock Report

Market Cap: €61.2m

BRAIN Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aryan Moelker

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.2yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

Apr 19
BRAIN Biotech AG (ETR:BNN) Shares Could Be 36% Below Their Intrinsic Value Estimate

BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Mar 28
BRAIN Biotech AG's (ETR:BNN) P/S Still Appears To Be Reasonable

Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Feb 16
Is BRAIN Biotech (ETR:BNN) A Risky Investment?

Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Sep 13
Here's Why BRAIN Biotech (ETR:BNN) Can Afford Some Debt

Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Mar 21
Here's What B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shareholder Ownership Structure Looks Like

Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

Feb 14
Is B.R.A.I.N. Biotechnology Research and Information Network (ETR:BNN) Weighed On By Its Debt Load?

When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

Jan 18
When Will B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) Breakeven?

How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 31
How Much Did B.R.A.I.N. Biotechnology Research and Information Network's(ETR:BNN) Shareholders Earn From Share Price Movements Over The Last Three Years?

Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Dec 10
Are Institutions Heavily Invested In B.R.A.I.N. Biotechnology Research and Information Network AG's (ETR:BNN) Shares?

Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

Nov 17
Should You Investigate B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) At €7.30?

CEO Compensation Analysis

How has Aryan Moelker's remuneration changed compared to BRAIN Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-€8m

Sep 30 2023n/an/a

-€8m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€7m

Dec 31 2022n/an/a

-€7m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Compensation vs Market: Insufficient data to establish whether Aryan's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Aryan's compensation has increased whilst the company is unprofitable.

CEO

Aryan Moelker

4.2yrs

Tenure

€957,000

Compensation

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Leadership Team

NamePositionTenureCompensationOwnership
Adriaan Moelker
Chairman of the Management Board & CEO4.2yrs€957.00kno data
Ulrich Putsch
Co-Founderno datano datano data
Michael Schneiders
CFO & Member of Management Board1.5yrsno datano data
Ute Dechert
Vice President of Human Resources & Processes3.5yrsno datano data
Jurgen Eck
Consultant4.3yrs€392.00kno data
Martin Langer
MD & Executive VPno datano datano data
Alexander Pelzer
VP and Head of Research & Development - Zwingenberg1.3yrsno datano data
Robbert Hoekstra
Head of Group Finance1.5yrsno datano data
Paul Scholz
Technical Lead of Genome Editing Developmentno datano datano data

2.5yrs

Average Tenure

55.5yo

Average Age

Experienced Management: BNN's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wiltrud Treffenfeldt
Independent Member of Supervisory Board3.5yrs€28.00kno data
Stephen Catling
Independent Member of Supervisory Board3.5yrs€31.00kno data
Michael Majerus
Independent Chairman of the Supervisory Board5.1yrs€51.00kno data
Anna Eichhorn
Vice Chairwoman of the Supervisory Board7.1yrs€53.00kno data
Christine Uekert
Independent Supervisory Board Member1.1yrsno datano data
Florian Schnabel
Supervisory Board Member1.1yrsno datano data

3.5yrs

Average Tenure

56yo

Average Age

Experienced Board: BNN's board of directors are considered experienced (3.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.